Anbio Biotechnology Class A Ordinary Shares (NNNN)

NASDAQ·Healthcare·Medical - Instruments & Supplies

$15.59

-7.30%

Mkt Cap $684.26M

No analyst coverage available

We don't have analyst ratings or price target data for Anbio Biotechnology Class A Ordinary Shares yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.